Biolive
PrivateLast Round
VC Round
Mar 2, 2020
Est. Valuation
$30M
Company Overview
Biolive operates in Energy & Sustainability and is based in Turkey. Its latest recorded funding round was a VC Round in March 2020.
Biolive is a biotechnology company that develops and produces bio-based plastic granules from olive seeds.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Advanced Materials, Circular Economy, Clean Manufacturing, Waste Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolive Comparables
Compare Biolive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BUYO Bioplastics | 83% | |
| Sulapac | 82% | |
| Lignin Industries | 81% |
For institutional investors. Book with your work email.
Biolive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 2, 2020 | ||||
| Seed | Jun 10, 2017 |
For institutional investors. Book with your work email.
Biolive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vestel Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2020
Raised $30M post-money round led by Vestel Ventures.
- Jun 10, 2017
Seed round led by Vestel Ventures.
For institutional investors. Book with your work email.
Biolive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biolive's valuation, stock price, and market status.
Is Biolive a public or private company?
Biolive is a private company.
What is the current stock price of Biolive?
Biolive is a private company, so its shares have no public market price. Caplight tracks Biolive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biolive worth (valuation)?
Biolive's valuation is estimated at $30.0M based on funding round data.
Can I buy Biolive stock?
Biolive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biolive's last funding round?
Biolive's most recent funding round was VC Round on March 2, 2020.
Who are the main investors in Biolive?
Key investors in Biolive include Vestel Ventures.
Will Biolive IPO soon?
No public IPO plans have been announced for Biolive.
How can I track Biolive secondary market activity?
Caplight tracks bids, offers, and trades in Biolive's shares on secondary markets.